Thyroid Nodules and Cancer: How Does Molecular Profiling Influence Surgery? (C) (No CME)
This session has been identified and designated as Credit to Meet ACS Accreditation/Verification Requirements for Cancer.
The incidence of thyroid cancer and thyroid surgery is increasing each year. Many lesions are removed based on indeterminate fine-needle biopsy results by the Bethesda classification system. In indeterminate needle biopsy results, a challenge remains for guiding patients with the safest options for care. Recently, genetic evaluation of thyroid needle biopsy samples has become available to help with decision making for indeterminate lesions. In this session, experts will provide their own approach to when they consider genetic testing of value in the evaluation of thyroid nodules. Emphasis will be placed on studies that demonstrate sensitivity and specificity of genetic testing and how cost may relate to outcomes.
Russell B. Smith, MD, FACS, Jacksonville, FL
- Afirma and Rosetta Testing for Indeterminate Nodules
Jennifer L. Marti, MD, FACS, New York, NY
- ThyroSeq and ThyGenX/ThyraMIR Testing for Indeterminate Nodules
Michael W. Yeh, MD, FACS, Los Angeles, CA
- Molecular Testing in Unique Populations
Erik K. Alexander, MD, Boston, MA
- Molecular Testing: Does It Really Help?
Jon Russell, MD
- Case Presentations
Linwah Yip, MD, FACS, Pittsburgh, PA
- Practicing surgeons
- Apply new knowledge and ideas to improve their surgical practice
- Adapt concepts and quality measures in support of research advancements
- Enhance the quality of patient care
- For questions about the course content, please contact firstname.lastname@example.org.
- If you have any technical questions, contact email@example.com.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website: http://www.accme.org/requirements/accreditation-requirements-cme-providers/policies-and-definitions/financial-relationships-and-conflicts-interest
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.
(Download the full list of disclosures.)
Faculty and Disclosures
Russell B. Smith, MD, FACS, Jacksonville, FL - No Disclosures
Jennifer L. Marti, MD, FACS, New York, NY - No Disclosures
Michael W. Yeh, MD, FACS, Los Angeles, CA - No Disclosures
Erik K. Alexander, MD, Boston, MA - Asuragen, Veracyte, Roche: research support & consultant: PI
Ralph P. Tufano, MD, MBA, FACS, Baltimore, MD - Hemostatix, Medtronic: Consultant, Consulting fee
Linwah Yip, MD, FACS, Pittsburgh, PA - EMMI Solutions: Compensation: Content reviewer, UptoDate: Compensation: Content chapter co-author
Program Committee and Disclosures
CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - No Disclosures
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - No Disclosures
David C. Borgstrom, MD, FACS, Morgantown, WV - No Disclosures
Daniel L. Dent, MD, FACS, San Antonio, TX - No Disclosures
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Audra A. Duncan, MD, FACS, London, ON - No Disclosures
Mariam F. Eskander, MD, Boston, MA - No Disclosures
Paula Ferrada, MD, FACS, Richmond, VA - No Disclosures
Neil H. Hyman, MD, FACS, Chicago, IL - No Disclosures
Martin S. Karpeh, Jr., MD, FACS, New York, NY - No Disclosures
Dennis H. Kraus, MD, FACS, New York, NY - No Disclosures
Kenneth W. Sharp, MD, FACS, Nashville, TN - No Disclosures
David A. Spain, MD, FACS, Stanford, CA - No Disclosures
Mary T. Hawn, MD, FACS, Stanford, CA - No Disclosures
Daniel M. Herron, MD, FACS, FASBMS, New York, NY - No Disclosures
Barbara Lee Bass, MD, FACS, FRCS(Hon), Houston, TX - No Disclosures
Quan-Yang Duh, MD, FACS, San Francisco, CA - No Disclosures
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - No Disclosures
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - No Disclosures
Valerie W. Rusch, MD, FACS, New York, NY - No Disclosures
A Certificate of Completion will be awarded.
This educational activity is not eligible for CME or CE credits.
- 0.00 AMA PRA Category 1 Credit™
- 0.00 Certificate of Completion
- 0.00 Self Assessment Credit